Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1621.35
-17.95 (-1.09%)
< Home < Back

Sun Pharmaceutical reports 5% fall in Q3 consolidated net profit

Date: 15-02-2017

Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2016.  

The company has reported a net loss of Rs 162.66 crore for the quarter ended December 31, 2016 as compared to a net loss of Rs 142.27 crore for the same quarter in the previous year. However, total income of the company increased by 4.38% at Rs 2012.81 crore for the quarter under review as compared Rs 1928.39 crore for the corresponding quarter previous year.        

On the consolidated basis, the company has reported 4.73% fall in its net profit after taxes, non-controlling interest and share of profit of associates & joint ventures at Rs 1471.82 crore for the quarter ended December 31, 2016, as compared to Rs 1544.85 crore for the same quarter in the previous year. However, total income of the company increased by 10.14% at Rs 8034.81 crore for the quarter under review as compared Rs 7295.20 crore for the corresponding quarter previous year.